AOD-9604 (Advanced Obesity Drug) is a 16-amino acid peptide fragment representing the C-terminal end (177–191) of the human growth hormone (hGH) molecule, with an added tyrosine at the N-terminal for stability. While retail "diet" brands market it as a simple weight-loss aid, PepGen Lab provides the analytical-grade fragment required to investigate the specific pathways of adipose tissue reduction without the systemic risks of full-length hGH.

The Mechanism: Stimulating Lipolysis, Inhibiting Lipogenesis

Full-length growth hormone (hGH) is known for its potent fat-burning effects, but it also carries the risk of inducing insulin resistance and elevating IGF-1 levels. AOD-9604 was engineered to isolate the metabolic benefits of hGH while stripping away its detrimental effects on glucose metabolism.

In controlled research environments, AOD-9604 functions through a dual-action metabolic shift:

Stimulation of Lipolysis: It triggers the breakdown of stored triglycerides into free fatty acids by mimicking hGH’s interaction with Beta-3 Adrenergic Receptors found on adipocytes.

Inhibition of Lipogenesis: It disrupts the metabolic pathways responsible for transforming non-fatty foods into body fat, effectively preventing the formation of new fat cells.

Why Purity >99% is Non-Negotiable for AOD-9604

The AOD-9604 sequence is notoriously fragile. Most "Retail Grade" versions found online are plagued by Deletion Sequences and Racemization (the "flipping" of amino acid mirror images).

The Problem: If the tyrosine at the N-terminal or the disulfide bond between cysteine residues is compromised during synthesis, the peptide loses its ability to bind to the adipose receptors.

The Consequence: Researchers using <95% pure AOD-9604 often report "inconsistent results" because half of their material is a degraded, biologically inactive fragment that cannot trigger the lipolytic pathway.

At PepGen Lab, our Ultra-High Purity (>99%) ensures that every molecule in the vial is the exact 177–191 fragment. This precision is required to achieve a linear, predictable dose-response in metabolic research.

Bypassing the IGF-1 Hazard

The primary reason AOD-9604 is a superior research model over hGH is its Metabolic Specificity. Unlike full hGH, AOD-9604 does not compete for the hGH receptor and does not trigger an increase in IGF-1 (Insulin-like Growth Factor-1).

This allows researchers to study fat metabolism in isolation, without the confounding variables of systemic growth stimulation, bone density changes, or glucose intolerance.

Real-World Research Impact: The Purity Audit

Variable                     Retail "Diet" Grade AOD                       PepGen Lab AOD-9604 (>99%)

Peptide Integrity.             High levels of deletion sequences                           Complete 177–191 Sequence

Metabolic Target              Inconsistent Adipocyte Binding                               Specific Beta-3 Receptor Agonism

IGF-1 Profile.                       Potential contamination risks                                   Zero impact on IGF-1 levels

HPLC Profile                       Multiple "noise" peaks                                                 Single, sharp Analytical Peak 

Scientific References & Verification

For researchers requiring peer-reviewed validation:

Lipolytic Action of AOD-9604: Metabolic Effects of the hGH C-terminal Fragment (PubMed)

Safety & IGF-1 Specificity: Clinical Evaluation of AOD-9604 (Journal of Endocrinology & Metabolism)

Mechanism of Fat Metabolism: Lipogenesis Inhibition in Research Models (ScienceDirect)

The Competitive Edge

If your AOD-9604 doesn't come with a batch-specific chromatogram showing >99% purity, you aren't conducting metabolic research—you’re testing degraded proteins. In the fight against metabolic dysfunction, precision is the only weapon that matters.

Page Disclaimer:

 The information provided in this section is intended strictly for informational and research purposes only. Our articles discuss published studies, emerging scientific discussions, and general laboratory topics related to research compounds. Nothing in this section is intended to diagnose, treat, cure, or prevent any disease.